Business Description
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Share Class Description:
MEX:CNMD: Ordinary SharesDescription
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.01 | |||||
| Debt-to-EBITDA | 3.49 | |||||
| Interest Coverage | 5.22 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 2.25 | |||||
| Beneish M-Score | -2.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | 15 | |||||
| 3-Year EPS without NRI Growth Rate | 120.9 | |||||
| 3-Year FCF Growth Rate | 24.4 | |||||
| 3-Year Book Growth Rate | 3.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 17.21 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.26 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 93.48 | |||||
| 14-Day RSI | 90.9 | |||||
| 6-1 Month Momentum % | 11.67 | |||||
| 12-1 Month Momentum % | -22.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.27 | |||||
| Quick Ratio | 1.06 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 208.47 | |||||
| Days Sales Outstanding | 67.12 | |||||
| Days Payable | 61.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.21 | |||||
| 3-Year Average Share Buyback Ratio | -2.1 | |||||
| Shareholder Yield % | 4.79 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.65 | |||||
| Operating Margin % | 15.37 | |||||
| Net Margin % | 10.23 | |||||
| FCF Margin % | 12.98 | |||||
| ROE % | 15.32 | |||||
| ROA % | 5.71 | |||||
| ROIC % | 7.47 | |||||
| 3-Year ROIIC % | -34.27 | |||||
| ROC (Joel Greenblatt) % | 46.57 | |||||
| ROCE % | 9.89 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.08 | |||||
| Forward PE Ratio | 14.55 | |||||
| PE Ratio without NRI | 17.45 | |||||
| Shiller PE Ratio | 52.21 | |||||
| Price-to-Owner-Earnings | 11.2 | |||||
| PS Ratio | 1.64 | |||||
| PB Ratio | 2.24 | |||||
| Price-to-Free-Cash-Flow | 12.74 | |||||
| Price-to-Operating-Cash-Flow | 11.75 | |||||
| EV-to-EBIT | 15.12 | |||||
| EV-to-EBITDA | 11.09 | |||||
| EV-to-Revenue | 2.32 | |||||
| EV-to-FCF | 18.02 | |||||
| Price-to-GF-Value | 0.56 | |||||
| Price-to-Projected-FCF | 1.41 | |||||
| Price-to-Median-PS-Value | 0.68 | |||||
| Earnings Yield (Greenblatt) % | 6.61 | |||||
| FCF Yield % | 7.94 | |||||
| Forward Rate of Return (Yacktman) % | 3.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 23,107.927 | ||
| EPS (TTM) (MXN) | 76.85 | ||
| Beta | -0.1 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.63 | ||
| Volatility % | 34.87 | ||
| 14-Day RSI | 90.9 | ||
| 14-Day ATR (MXN) | 0.008857 | ||
| 20-Day SMA (MXN) | 1454 | ||
| 12-1 Month Momentum % | -22.82 | ||
| 52-Week Range (MXN) | 1179 - 1883.89 | ||
| Shares Outstanding (Mil) | 30.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conmed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conmed Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Conmed Corp Frequently Asked Questions
What is Conmed Corp(MEX:CNMD)'s stock price today?
The current price of MEX:CNMD is MXN1454.00. The 52 week high of MEX:CNMD is MXN1883.89 and 52 week low is MXN1179.00.
When is next earnings date of Conmed Corp(MEX:CNMD)?
The next earnings date of Conmed Corp(MEX:CNMD) is 2025-01-31 Est..
Does Conmed Corp(MEX:CNMD) pay dividends? If so, how much?
Conmed Corp(MEX:CNMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers